The Business Research Company’s report on the Atrial Fibrillation Market provides insights into the global market size, growth rate, regional distribution, competitive landscape, key segments, emerging trends, and strategic opportunities.
How are market drivers shaping the future growth trajectory of the atrial fibrillation industry?
The increase in the geriatric population is expected to drive the atrial fibrillation market forward. The geriatric population refers to adults 65 and older who are more likely to fall due to various factors, such as postural hypotension and balance or gait problems. Age factor and conduction disturbances are present on the surface electrocardiogram before AF onset in most geriatric patients. For instance, in October 2022, according to the World Health Organization, a Switzerland-based specialized agency of the United Nations responsible for international public health, six people in the world will be aged 60 years or older by 2030. At this point, there will be 1.4 billion people, up from 1 billion in 2020, who are 60 years of age or older. The number of individuals 60 and older in the world will double (to 2.1 billion) by the year 2050. Between 2020 and 2050, there will be 426 million more people who are 80 years of age or older than there are today. Therefore, the growing geriatric population is driving the growth of the atrial fibrillation market.
Access Your Free Sample of the Global Atrial Fibrillation Market Report – Get Insights Now!
Atrial Fibrillation Market Report 2025, Demand And Analysis Sample
What is the estimated market size of the atrial fibrillation sector by 2029, based on current forecasts?
The atrial fibrillation market size has grown rapidly in recent years. It will grow from $13.56 billion in 2024 to $15.14 billion in 2025 at a compound annual growth rate (CAGR) of 11.7%. The growth in the historic period can be attributed to increasing awareness and screening programs, technological innovations in treatment, increasing healthcare expenditure, clinical research and drug development, genetic predisposition.
The atrial fibrillation market size is expected to see rapid growth in the next few years. It will grow to $24.93 billion in 2029 at a compound annual growth rate (CAGR) of 13.3%. The growth in the forecast period can be attributed to focus on stroke prevention, patient and physician education programs, global initiatives for cardiovascular health, increasing electrophysiology procedures, customization of treatment plans, government initiatives for cardiovascular disease prevention. Major trends in the forecast period include advancements in diagnostic technologies, rise in the incidence of atrial fibrillation, advancements in catheter ablation techniques, emergence of novel oral anticoagulants (NOACs), integration of wearable technologies for monitoring, expanding role of telemedicine in AF management, advancements in implantable devices.
Gain Exclusive Market Insights—Customize Your Research Report Today For Fast Delivery!
Atrial Fibrillation Market Report 2025, Demand And Analysis Customise
Who are the top players in the atrial fibrillation market?
Major companies operating in the atrial fibrillation market are AtriCure Inc., Johnson & Johnson Private Limited, Abbott Laboratories, C.H. Boehringer Sohn AG & Co. KG, Biotronik Se & Co. Kg, Boston Scientific Corporation, Bristol-Myers Squibb Company, CardioFocus Inc., Sanofi S.A, Medtronic PLC, Biosense Webster Inc., MicroPort Scientific Corporation, Siemens AG, Acutus Medical Inc., AEGEA Medical Inc., Apama Medical Inc., Aria CV Inc., Armetheon Inc., BioSig Technologies Inc., Cardialen Inc., CardioRobotics Inc., CardioInsight Technologies Inc., Circa Scientific LLC, CorWave SA, EpiEP Inc., Farapulse Inc., Fibralign Corporation, Impulse Dynamics NV, JenaValve Technology Inc., Kardium Inc.
What are the major trends in the atrial fibrillation market?
Major companies in the atrial fibrillation market are launching innovative products and solutions such as patient-centric clinical decision support tools to strengthen their position in the market. Clinical decision support tools (CDST) are software or electronic systems designed to assist healthcare professionals in making informed and timely decisions about patient care. These tools are developed to integrate relevant clinical information from various sources. For instance, in August 2023, GE HealthCare, a US-based multinational medical technology company launched the CardioVisio, a patient-centered clinical decision support tool to help doctors drive evidence-based clinical decision support guided by current atrial fibrillation guidelines and visualize longitudinal data from various data sources relevant for illness progression. CardioVisio for atrial fibrillation, can assist cardiologists with in streamlining clinician image interpretation and to provide a view of the history of the patient’s heart as well as their healthcare journey, including previous diagnoses, prescribed medications, interventions, and comorbidities.
Which geography holds the highest atrial fibrillation market share?
North America was the largest region in the atrial fibrillation market in 2024. Asia-Pacific is expected to be the fastest-growing region in the atrial fibrillation market report forecast period. The regions covered in the atrial fibrillation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Order Your Report Now For Swift Delivery
Atrial Fibrillation Market Report 2025, Demand And Analysis
How do different segments contribute to the overall expansion of the atrial fibrillation market?
The atrial fibrillation market covered in this report is segmented –
1) By Type: Surgical, Non-Surgical
2) By Technology: Radiofrequency, Laser, Cryotherapy, Other Technologies
3) By Treatment Type: Pharmacological Treatment, Non-pharmacological Treatment, Maze Surgery, Electric Cardioversion
4) By End User: Hospitals, Electrophysiology Labs, Ambulatory Surgical Centers
Subsegments:
1) By Surgical: Catheter Ablation, Maze Procedure, Hybrid Ablation Procedures
2) By Non-Surgical: Antiarrhythmic Drugs, Anticoagulants, Cardioversion Procedures, Device Implants
Purchase The Exclusive Report Now To Unlock Valuable Market Insights:
Atrial Fibrillation Market Report 2025, Demand And Analysis
How is the atrial fibrillation market defined, and what are its core characteristics?
Atrial fibrillation refers to a disorder of the heart caused by an abnormality in the normal sequence of electrical impulses that changes the rate or rhythm at which the heart beats and begins in the heart’s upper chambers (atria). Electrical impulses can be too fast, too slow, or erratically occurring, resulting in irregular heartbeats.
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: The Business Research Company | LinkedIn
